Pregled bibliografske jedinice broj: 1181209
Immunotherapy of urinary bladder carcinoma
Immunotherapy of urinary bladder carcinoma // Libri Oncologici : Croatian Journal of Oncology, 45 (2017), 2-3; 52-54 (recenziran, članak, znanstveni)
CROSBI ID: 1181209 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Immunotherapy of urinary bladder carcinoma
Autori
Zahirović, Dag ; Pavlović Ružić, Ira ; Belac Lovasić, Ingrid
Izvornik
Libri Oncologici : Croatian Journal of Oncology (2584-3826) 45
(2017), 2-3;
52-54
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
urothelial carcinoma ; immunotherapy ; checkpoint inhibitors
Sažetak
Urothelial urinary bladder carcinoma represents 9th most common malignancy in the world. This disease is held responsable for more than 165000 deaths throughout the world. In the past 30 years there were no major advances in treatment of this tumor. Chemotherapy regimens used for treatment are based on platinum compounds. In a recent time a series of immune system modulating drugs have been developed. This drugs have achieved excellent results in the treatment of urinary bladder carcinoma.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Rijeka,
Klinički bolnički centar Rijeka
